614 related articles for article (PubMed ID: 34237949)
1. Triazavirin might be the new hope to fight Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Hudecová IMJČGKMPL
Ceska Slov Farm; 2021; 70(1):18-25. PubMed ID: 34237949
[TBL] [Abstract][Full Text] [Related]
2. Triazavirin - Potential Inhibitor for 2019-nCoV Coronavirus M Protease: A DFT Study.
Shahab S; Sheikhi M
Curr Mol Med; 2021; 21(8):645-654. PubMed ID: 32436829
[TBL] [Abstract][Full Text] [Related]
3. Triazavirin-A Novel Effective Antiviral Drug.
Chupakhin ON; Rusinov VL; Varaksin MV; Ulomskiy EN; Savateev KV; Butorin II; Du W; Sun Z; Charushin VN
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498864
[TBL] [Abstract][Full Text] [Related]
4. Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus.
Al-Beltagi S; Preda CA; Goulding LV; James J; Pu J; Skinner P; Jiang Z; Wang BL; Yang J; Banyard AC; Mellits KH; Gershkovich P; Hayes CJ; Nguyen-Van-Tam J; Brown IH; Liu J; Chang KC
Viruses; 2021 Feb; 13(2):. PubMed ID: 33546185
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of pathological changes and pathogenic mechanisms caused by H1N1 influenza virus, highly pathogenic H5N1 avian influenza virus, SARS-CoV, MERS-CoV and 2019-nCoV].
Liu M; Feng RE; Li Q; Zhang HK; Wang YG
Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):511-516. PubMed ID: 32392945
[TBL] [Abstract][Full Text] [Related]
6. Interaction and antiviral treatment of coinfection between SARS-CoV-2 and influenza in vitro.
Liu D; Leung KY; Lam HY; Zhang R; Fan Y; Xie X; Chan KH; Hung IF
Virus Res; 2024 Jul; 345():199371. PubMed ID: 38621598
[TBL] [Abstract][Full Text] [Related]
7. A novel film spray containing curcumin inhibits SARS-CoV-2 and influenza virus infection and enhances mucosal immunity.
Nittayananta W; Lerdsamran H; Chutiwitoonchai N; Promsong A; Srichana T; Netsomboon K; Prasertsopon J; Kerdto J
Virol J; 2024 Jan; 21(1):26. PubMed ID: 38263162
[TBL] [Abstract][Full Text] [Related]
8. N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19)
Lackner M; Rössler A; Volland A; Stadtmüller MN; Müllauer B; Banki Z; Ströhle J; Luttick A; Fenner J; Sarg B; Kremser L; Tone P; Stoiber H; von Laer D; Wolff T; Schwarz C; Nagl M
Emerg Microbes Infect; 2022 Dec; 11(1):1293-1307. PubMed ID: 35418279
[No Abstract] [Full Text] [Related]
9. Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication.
Tripp RA; Martin DE
Viruses; 2022 Mar; 14(3):. PubMed ID: 35337018
[TBL] [Abstract][Full Text] [Related]
10. No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020.
Panatto D; Orsi A; Pennati BM; Lai PL; Mosca S; Bruzzone B; Caligiuri P; Napoli C; Bertamino E; Orsi GB; Manini I; Loconsole D; Centrone F; Pandolfi E; Ciofi Degli Atti ML; Concato C; Linardos G; Onetti Muda A; Raponi M; Piccioni L; Rizzo C; Chironna M; Icardi G
PLoS One; 2021; 16(12):e0260947. PubMed ID: 34874956
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of triazavirin (riamilovir)-based treatment for coronavirus disease 2019 (COVID-19) in clinical trials and preliminary practical experiences.
Malík I; Kováč G; Hudecova L
Ceska Slov Farm; 2022; 71(6):239-244. PubMed ID: 36513517
[TBL] [Abstract][Full Text] [Related]
12. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
[TBL] [Abstract][Full Text] [Related]
13. XiaoEr LianHuaQinqGan alleviates viral pneumonia in mice infected by influenza A and respiratory syncytial viruses.
Li W; Li T; Zhao C; Song T; Mi Y; Chuangfeng Z; Hou Y; Jia Z
Pharm Biol; 2022 Dec; 60(1):2355-2366. PubMed ID: 36444944
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of new β-D-N
An YJ; Choi SM; Choi ER; Nam YE; Seo EW; Ahn SB; Jang Y; Kim M; Cho JH
Bioorg Med Chem Lett; 2023 Mar; 83():129174. PubMed ID: 36764470
[TBL] [Abstract][Full Text] [Related]
15. A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
Ao Z; Ouyang MJ; Olukitibi TA; Warner B; Vendramelli R; Truong T; Meilleur C; Zhang M; Kung S; Fowke KR; Kobasa D; Yao X
J Virol; 2022 Sep; 96(18):e0133722. PubMed ID: 36069551
[TBL] [Abstract][Full Text] [Related]
16. Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus.
Ekanger CT; Zhou F; Bohan D; Lotsberg ML; Ramnefjell M; Hoareau L; Røsland GV; Lu N; Aanerud M; Gärtner F; Salminen PR; Bentsen M; Halvorsen T; Ræder H; Akslen LA; Langeland N; Cox R; Maury W; Stuhr LEB; Lorens JB; Engelsen AST
Front Cell Infect Microbiol; 2022; 12():841447. PubMed ID: 35360113
[TBL] [Abstract][Full Text] [Related]
17. 4'-Fluorouridine mitigates lethal infection with pandemic human and highly pathogenic avian influenza viruses.
Lieber CM; Aggarwal M; Yoon JJ; Cox RM; Kang HJ; Sourimant J; Toots M; Johnson SK; Jones CA; Sticher ZM; Kolykhalov AA; Saindane MT; Tompkins SM; Planz O; Painter GR; Natchus MG; Sakamoto K; Plemper RK
PLoS Pathog; 2023 Apr; 19(4):e1011342. PubMed ID: 37068076
[TBL] [Abstract][Full Text] [Related]
18. Influenza A(H1N1)pdm09 Virus but Not Respiratory Syncytial Virus Interferes with SARS-CoV-2 Replication during Sequential Infections in Human Nasal Epithelial Cells.
Fage C; Hénaut M; Carbonneau J; Piret J; Boivin G
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215988
[TBL] [Abstract][Full Text] [Related]
19. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets.
Huang Y; Skarlupka AL; Jang H; Blas-Machado U; Holladay N; Hogan RJ; Ross TM
J Virol; 2022 Mar; 96(5):e0179121. PubMed ID: 34936487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
